CN103623242B - Medicament for treating hyperlipemia on inspection - Google Patents

Abstract

The invention relates to a medicament for treating hyperlipemia on inspection. The medicament is prepared from the following bulk drugs in parts by weight: 6 parts of atractylodes macrocephala koidz, 8 parts of rhodobryum giganteum, 5 parts of herba lepisori, 3 parts of radix codonopsis, 5 parts of common pistache fruit, 6 parts of poria, 3 parts of costusroot, 2 parts of uncinata spikemoss herb, 3 parts of rotala rotundifolia, 9 parts of medlar, 2 parts of polypodiodes amoena, 2 parts of jenkine dendrobium, 5 parts of cornus officinalis, 2 parts of smilax riparia, and 2 parts of common adenostema herb. Nature medicines are used in the medicament for treating hyperlipemia on inspection, so that the medicament has the advantages of quick response, good curative effect and no toxic or side effect.

Description

A kind of medicament checking treatment hyperlipemia

Technical field

The present invention relates to field of medicaments, specifically, relate to a kind of medicament checking treatment hyperlipemia.

Background technology

Hyperlipemia is atherosclerotic material base and principal element, is the risk factor of the disease such as coronary heart disease, hypertension.Studying the method for inspection effectively being treated hyperlipemia clinically always.

Summary of the invention

The object of this invention is to provide a kind of medicament checking treatment hyperlipemia.

In order to realize object of the present invention, the invention provides a kind of medicament checking treatment hyperlipemia, it is made up by weight of following bulk drugs: the Rhizoma Atractylodis Macrocephalae 6 parts, Rhizoma Arisaematis 8 parts, Herba Lepisori Thunbergiani 5 parts, Radix Codonopsis 3 parts, Fructus Pistaciae Verae 5 parts, 6 parts, Poria, the Radix Aucklandiae 3 parts, CUIYUNCAO 2 parts, water Semen Sojae Preparatum 3 parts, Fructus Lycii 9 parts, native broken benefit 2 parts, Dendrobium jenkinsii Wall ex Lindl． 2 parts, Fructus Corni 5 parts, Radix et Rhizoma Smilacis Ripariae 2 parts and Herba Adenostemmatis 2 parts.

Preferably, described medicament is tablet, dispersible tablet, rapidly dissolving tablet, powder or granule.

In the present compositions, the Rhizoma Atractylodis Macrocephalae, Rhizoma Arisaematis, Herba Lepisori Thunbergiani are monarch drug; Radix Codonopsis, Fructus Pistaciae Verae, Poria, the Radix Aucklandiae are ministerial drug; CUIYUNCAO, water Semen Sojae Preparatum, Fructus Lycii, native broken benefit are adjuvant drug; Dendrobium jenkinsii Wall ex Lindl．, Fructus Corni, Radix et Rhizoma Smilacis Ripariae and Herba Adenostemmatis for making medicine, various composition synergism, thus play optimum efficiency.

Inspection of the present invention is treated in the medicament of hyperlipemia and use natural drug, therefore it has instant effect, good effect, the advantage that has no side effect.

Accompanying drawing explanation

With reference to " Chinese medicine voluminous dictionary " second edition, being described as follows of some crude drug used in the present invention:

Fig. 1 is the explanation of Rhizoma Arisaematis;

Fig. 2 is the explanation of Herba Lepisori Thunbergiani;

Fig. 3 is the explanation of Fructus Pistaciae Verae;

Fig. 4 is the explanation of CUIYUNCAO;

Fig. 5 is the explanation of water Semen Sojae Preparatum;

Fig. 6 is the explanation of native broken benefit;

Fig. 7 is the explanation of Dendrobium jenkinsii Wall ex Lindl．;

Fig. 8 is the explanation of Radix et Rhizoma Smilacis Ripariae;

Fig. 9 is the explanation of Herba Adenostemmatis.

Detailed description of the invention

Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.

The preparation of embodiment 1 powder of the present invention

Get the Rhizoma Atractylodis Macrocephalae 60 grams, Rhizoma Arisaematis 80 grams, Herba Lepisori Thunbergiani 50 grams, Radix Codonopsis 30 grams, Fructus Pistaciae Verae 50 grams, 60 grams, Poria, the Radix Aucklandiae 30 grams, CUIYUNCAO 20 grams, water Semen Sojae Preparatum 30 grams, Fructus Lycii 90 grams, native broken benefit 20 grams, Dendrobium jenkinsii Wall ex Lindl． 20 grams, Fructus Corni 50 grams, Radix et Rhizoma Smilacis Ripariae 20 grams and Herba Adenostemmatis 20 grams, pulverize, cross 100 mesh sieves, then sucrose 350 grams is added, mixing, uniform distribution loads in 100 bags and get final product.

Experimental example

Diagnostic criteria

With reference to " guideline of clinical investigations of new Chinese medicine inspection upper treatment hyperlipemia " (Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: China Medical Science Press, 2002:85) and national dyslipidemia in 2007 visit and control " Blood Lipid Abnormality in Chinese Adults guideline of prevention and treatment " that countermeasure group writes and u.s. national cholesterol education program (NCEP) adult treatment expert group (ATP) is drafted about the guide (the 3rd edition) (ATP-III) reducing cholesterol control CHD.Patient surveys the one that blood fat meets following situation and can make a definite diagnosis: (1) cholesterol (TC) >=1.7mmol/L; Low density lipoprotein, LDL (LDL-C) >=3.6mmol/L; High density lipoprotein (HDL-C)≤1.0mmol/L.

Selector closes 40 routine hyperlipidemia patients of standard of stating, and man 20 example, female 20 example, the mean age is 52 years old.

Use powder obtained in embodiment 1 to treat, wherein one day 1 time, oral one bag at every turn, treating 30 days is a course for the treatment of, treats 2 courses for the treatment of continuously.

Criterion of therapeutical effect

Reference " guideline of clinical investigations of new Chinese medicine inspection upper treatment hyperlipemia " (Zheng Xiao cornel. study of tcm new drug clinical guidance principle [S]. Beijing: China Medical Science Press, 2002:85) draft.Cure: after treatment, lipids detection recovers normal; Effective; After treatment, lipids detection reaches following any 1 person, and namely TC declines >=20%, or TG declines >=40%, or HDL-C rising >=0.26mmol/L, or HDL-C/LDL-C >=20%; Effective: after treatment, lipids detection reaches following any 1 person, i.e. TC decline <20%, or TG decline >=20%<40%, HDL-C rising >=0.104mmol/L<0.26mmol/L, or HDL-C/LDL-C >=10%<20%; Invalid: after treatment, lipids detection is not improved or improves and do not reach effective standard person.

Check the blood fat of patient through treatment, find cholesterol (TC) <1.5mmol/L of all patients; Low density lipoprotein, LDL (LDL-C) <3.5mmol/L; High density lipoprotein (HDL-C) is 1.2-2.0mmol/L, all meets normal blood lipids index clinically.Therefore visible, all patients all meet the standard of healing.

Patient before the treatment after all promoting the circulation of blood, routine urinalysis and draw the inspection of kidney merit, after medication, every inspection is showed no obvious abnormalities, and patient does not also tell special discomfort.

Claims (1)

1. treat the medicament of hyperlipemia for one kind, it is characterized in that, it is made up by weight of following bulk drugs: the Rhizoma Atractylodis Macrocephalae 6 parts, Rhizoma Arisaematis 8 parts, Herba Lepisori Thunbergiani 5 parts, Radix Codonopsis 3 parts, Fructus Pistaciae Verae 5 parts, 6 parts, Poria, the Radix Aucklandiae 3 parts, CUIYUNCAO 2 parts, water Semen Sojae Preparatum 3 parts, Fructus Lycii 9 parts, native broken benefit 2 parts, Dendrobium jenkinsii Wall ex Lindl． 2 parts, Fructus Corni 5 parts, Radix et Rhizoma Smilacis Ripariae 2 parts and Herba Adenostemmatis 2 parts.